Top News

Ambit Biosciences Raises $21M

San Diego-based Ambit Biosciences announced that it has raised a Series C funding of $21.0M led by Roche Venture Fund. The company is developing biopharmaceuticals based on a proprietary high throughput human kinase assay drug screening panel. Ambit is also backed by Avalon Ventures, Forward Ventures, GIMV, and Perseus-Soros BioPharmaceutical Fund. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel